Next Article in Journal
Development of CMX001 for the Treatment of Poxvirus Infections
Next Article in Special Issue
Clinical Management of HIV Drug Resistance
Previous Article in Journal
Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246
Previous Article in Special Issue
Molecular Basis for Drug Resistance in HIV-1 Protease
Article Menu

Article Versions

Export Article

Open AccessReview
Viruses 2010, 2(12), 2696-2739; doi:10.3390/v2122696

Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C

Departments of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA
*
Author to whom correspondence should be addressed.
Received: 24 October 2010 / Revised: 15 November 2010 / Accepted: 7 December 2010 / Published: 14 December 2010
(This article belongs to the Special Issue HIV Drug Resistance 2010)
Download PDF [586 KB, uploaded 12 May 2015]

Abstract

Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are the most prevalent deadly chronic viral diseases. HIV is treated by small molecule inhibitors. HBV is treated by immunomodulation and small molecule inhibitors. HCV is currently treated primarily by immunomodulation but many small molecules are in clinical development. Although HIV is a retrovirus, HBV is a double-stranded DNA virus, and HCV is a single-stranded RNA virus, antiviral drug resistance complicates the development of drugs and the successful treatment of each of these viruses. Although their replication cycles, therapeutic targets, and evolutionary mechanisms are different, the fundamental approaches to identifying and characterizing HIV, HBV, and HCV drug resistance are similar. This review describes the evolution of HIV, HBV, and HCV within individuals and populations and the genetic mechanisms associated with drug resistance to each of the antiviral drug classes used for their treatment.
Keywords: HIV; HBV; HCV; antiviral therapy; drug resistance; evolution; quasispecies HIV; HBV; HCV; antiviral therapy; drug resistance; evolution; quasispecies
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Margeridon-Thermet, S.; Shafer, R.W. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C. Viruses 2010, 2, 2696-2739.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top